Group 1 - The company held a board meeting on June 3, 2025, where all procedures complied with relevant laws and regulations [1] - The board approved a proposal to establish a private investment fund with a target fundraising size of RMB 1.5 billion, focusing on semiconductor and strategic emerging sectors [2] - The company plans to contribute up to RMB 735 million, representing no more than 49% of the fund's total size [2] Group 2 - The board approved adjustments to the 2025 restricted stock incentive plan due to 12 individuals no longer qualifying as incentive recipients, reducing the number of recipients from 2,470 to 2,458 [3] - The total number of restricted stocks to be granted remains unchanged, with adjustments made based on factors such as tenure and performance [3] - The board agreed to grant 10 million restricted stocks at a price of RMB 100 per share to the adjusted list of recipients on June 10, 2025 [4] Group 3 - A proposal was made to convene the second extraordinary general meeting of shareholders on June 26, 2025, which received unanimous approval from the board [4]

Investment Overview - The company has signed a partnership agreement with Jiang Sai Zhi Bo Le Equity Investment Management Co., Ltd., Zhejiang University Net New Technology Co., Ltd., and Hangzhou Jingye Intelligent Technology Co., Ltd. to jointly invest in Hangzhou Sai Zhi Zhu Long Venture Capital Partnership (Limited Partnership) [1] - The target total fundraising scale of the investment fund is RMB 100 million, with the company contributing RMB 33 million, accounting for 33% of the total fundraising scale [1] Fund Progress - The investment fund has completed the business registration process and obtained a business license from the market supervision and management department [2] - The fund has also completed the private investment fund registration procedures with the Asset Management Association of China, obtaining the Private Investment Fund Registration Certificate [2]

Group 1 - The company has announced its participation in the establishment of the Shanghai Chuangte Private Investment Fund Partnership (Limited Partnership), which has completed its business registration [1] - The fund has a total scale of 56 million yuan, with an initial capital contribution of 10 million yuan [1] - As of the announcement date, the initial capital contribution has been completed, with the following contributions from partners: Shanghai Shengtou Venture Capital Co., Ltd. (GP, manager) 1 million yuan, Shanghai Bailian Guotai Junan Chuangling Private Fund Partnership (Limited Partnership) 6 million yuan, Shanghai First Pharmaceutical Co., Ltd. (LP) 1 million yuan, Shanghai Fengxian Biotechnology Park Development Co., Ltd. (LP) 1 million yuan, and Huai'an Kechuang Industrial Investment Co., Ltd. (LP) 1 million yuan, totaling 10 million yuan [1]